Background/Aims: Quercetin, a flavonoid found in onions and other vegetables, has potential inhibitory effects on bone resorption in vivo and in vitro. In our previous study, we found that quercetin treatment reversed lipopolysaccharide (LPS)-induced inhibition of osteoblast differentiation through the mitogen-activated protein kinase (MAPK) pathway in MC3T3-E1 cells. In this study, we investigated the underlying mechanisms of pretreatment with quercetin on apoptosis and the inhibition of osteoblast differentiation in MC3T3-E1 cells induced by LPS. Methods: MC3T3-E1 osteoblasts were treated with quercetin for 2 h; cells were then incubated with LPS in the presence of quercetin for the indicated times. Cell viability was measured using the Cell Counting Kit-8 (CCK-8) assay, and cell apoptosis was evaluated using Hoechst 33258 staining. The mRNA expression levels of osteoblast-specific genes, Bax and caspase-3 were determined by real-time quantitative polymerase chain reaction (qPCR). Protein levels of osteoblast-specific genes, caspase-3, Bax, cytochrome c, Bcl-2, Bcl-XL, phosphorylated MAPKs and Wnt/β-catenin were measured using Western blot assays. The MAPK and Wnt/β-catenin signalling pathways were blocked prior to pretreatment with quercetin. Results: Pretreatment with quercetin significantly restored LPS-suppressed bone mineralization and the mRNA and protein expression levels of osteoblast-specific genes such as Osterix (OSX), runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP) and osteocalcin (OCN) in a dose-dependent manner. Pretreatment with quercetin also inhibited 
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Introduction
Bone is a dynamic tissue that constantly undergoes remodeling, a life-long coupled process of bone formation by osteoblasts and resorption by osteoclasts. An imbalance between bone formation and bone resorption results in excessive bone loss, a feature of chronic inflammatory diseases such as osteomyelitis, and bacterial arthritis and of infected orthopaedic implants [1] .
Lipopolysaccharide (LPS), a component of the outer membrane of all gram-negative bacteria, was shown to be capable of inducing bone resorption in vivo and in vitro [2] [3] [4] [5] . Furthermore, LPS is able to inhibit osteoblast differentiation and to induce apoptosis in vitro [6] [7] [8] [9] [10] . Currently, effective therapy against bacteria-induced bone destruction is limited to treatment with antibiotic regimens and surgical strategies for infective bone diseases. Therefore, the investigation of potential drugs that restore down-regulated osteoblast function remains a major goal in the prevention of bone destruction in infective bone diseases.
Quercetin, a dietary flavonoid, has been shown to inhibit bone loss by affecting osteoclastogenesis and by regulating a variety of systemic and local factors such as hormones and inflammatory cytokines [11] [12] [13] [14] [15] . However, the effect of quercetin on osteoblastogenesis remains a matter of controversy [16] [17] [18] [19] [20] [21] . In our previous study, we found quercetin reversed LPS-induced inhibition of osteoblast differentiation [22] . However, the effect of pretreatment with quercetin on LPS-induced apoptosis and the inhibition of osteoblast differentiation is still unclear.
Mitogen-activated protein kinase (MAPK) signalling pathways play a vital role in the progression of inflammatory responses and cell apoptosis in osteoblasts [9, 23, 24] . Quercetin has been reported to demonstrate an inhibitory effect on MAPK activation and cyclooxygenase-2 (COX-2) expression induced by LPS [15, [25] [26] [27] .
The Wnt/β-catenin signalling pathway also plays a vital role in regulating osteoblast differentiation and bone formation [28] [29] [30] . However, the mechanism of the Wnt/β-catenin signalling pathway in regulating the progression of the inflammatory responses in osteoblasts remains poorly understood.
Therefore, the aim of the present study was to evaluate the effect of pretreatment with quercetin on the apoptosis and osteoblast differentiation of MC3T3-E1 osteoblasts induced by LPS. Furthermore, we also examined the mechanism of pretreatment with quercetin on MAPK phosphorylation and Wnt/β-catenin signalling in MC3T3-E1 osteoblasts stimulated with LPS.
Materials and Methods
Reagents and antibodies
Escherichia coli LPS (serotype 055: B5), quercetin (Q4951, purity ≥ 95% by HPLC), β-glycerophosphate (β-GP), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), ascorbic acid and alizarin red S were purchased from Sigma Chemical Co (St Louis, MO, USA). The selective MAPK inhibitors SB203580, PD98059 and SP600125 were purchased from Cayman Chemical (Ann Arbor, Michigan, USA). The protease inhibitors cocktail, dexamethasone (Dex), and the selective Wnt/β-catenin inhibitor XAV939 were purchased from Selleck Chemicals (Houston, TX, USA). Antibodies to Bcl-2 (#2870), Bcl-xL (#2764), p38 MAPK (#9212), phosphorylated (p-)p38 (#9211), extracellular signal-regulated kinase (ERK)1/2 (#4695) and p-ERK1/2 (#4370) were purchased from Cell Signalling Technology, Inc. (Beverly, MA, USA). Antibodies to caspase-3 (sc-7148), Bax (sc-493), cytochrome c (sc-13156), JNK1/2 (sc-571), p-JNK1/2 (sc-12882), osterix (OSX; sc-393325), osteocalcin (OCN; sc-390877), ALP (sc-137213), β-actin (sc-47778), Wnt3 (sc-47778), β-catenin (sc-7963) and GSK3β (sc-9168) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). The antibody to runt-related transcription factor 2 (Runx2; ab76956) was purchased from Abcam (Cambridge, UK). The osteoblast-like cell line MC3T3-E1 was obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA). All other chemicals and reagents used in the present study were of analytical grade.
Cell culture MC3T3-E1 cells were grown in DMEM supplemented with 10% (v/v) FBS, 1% (v/v) penicillinstreptomycin solution, and 10 mM HEPES solution and were incubated at 37°C in 5% CO 2 humidified air. To examine the effect of quercetin on osteoblast differentiation stimulated with LPS, MC3T3-E1 cells at 5×10 4 cells/cm 2 were cultured in osteogenic differentiation medium (DMEM with 10% FBS, 10 mM HEPES, 50 μg/ml L-ascorbic acid and 10 mM β-GP) for 2 d. On differentiation day 3, cells were treated with quercetin at concentrations of 5, 10, 15, 25, or 50 μM or were treated without quercetin in osteogenic differentiation medium for 2 h, and then cells were incubated with LPS (100 ng/ml) in the presence of quercetin (5, 10, 15, 25, 50 μM) for the indicated time.
Cell viability assay
Cell viability was measured with the Cell Counting Kit-8 (CCK-8) assay (Beyotime Institute of Biotechnology, Shanghai, China). MC3T3-E1 cells at 5×10 3 cells/cm 2 were plated in 96-well culture plates and cultured in 0.1 ml of osteogenic differentiation medium. To evaluate the effect of quercetin on osteoblast viability, cells were treated with 10, 25, or 50 μM quercetin or without quercetin for 1, 3, 5, or 7 d. To evaluate the effect of quercetin on LPS-induced osteoblast viability, cells were pretreated with 5, 10, 20, 40, 50, 60, 80, 100 or 150 μM quercetin or without quercetin, and then cells were treated 100 ng/ml LPS or without LPS in the presence of quercetin for 1 or 3d. At the end of treatment, 10 μl of CCK-8 was added to each well. Cells were cultured for an additional 1 h. After shaking for 1 min, absorbance was measured at 450 nm using a microplate reader (Thermo Fisher Scientific Inc., Pittsburgh, USA). The experiment was performed in triplicate.
Study of osteoblast apoptosis
To measure apoptosis, we performed Hoechst 33258 staining (Beyotime Institute of Biotechnology) to visualize nuclear morphology and nuclear DNA fragmentation in osteoblasts. MC3T3-E1 cells (4×10 4 cells/cm 2 ) were seeded into 12-well plates and incubated overnight. Cells were pretreated with 5, 10, 15, 25 and 50 μM quercetin or without quercetin for 2 h, and then cells were treated with 100 ng/ml LPS or without LPS in the presence of quercetin for 1 d. At the end of the treatment, cells were washed with phosphate-buffered saline (PBS) to remove non-adherent cells, and the adherent cells were fixed in 4% paraformaldehyde solution for 10 min. After being washed with PBS, the cells were incubated with 0.2 mM Hoechst 33258 for 5 min in the dark. Cells with nuclei containing clearly condensed chromatin or cells with fragmented nuclei were scored as apoptotic; the results were expressed as the number of apoptotic cells. The images of apoptotic osteoblasts were obtained under a fluorescence microscope (Olympus IX71, Olympus Optical, Tokyo, Japan).
Determination of mineralized matrix
Mineralization in the MC3T3-E1 cells was determined by staining with alizarin red S, which selectively binds to calcium and yields a dark red stain. 
Quantitative real-time PCR
Total RNA was isolated using the TRIzol reagent (Invitrogen, Grand Island, NY, USA) and quantified by spectrophotometry. After isolation, 3 μg of total RNA from each sample was reverse transcribed (RT) into cDNA utilizing the HiFi-MMLV cDNA Kit (Beijing CoWin Biotech) according to the manufacturer's protocol. The primer sequences of osteoblast-specific genes, caspase-3, Bax and β-actin (Generay Biotech Co. Ltd, Shanghai, China) and the annealing temperatures used in this study are listed in Table 1 . Real-time PCR was performed with a RealSYBR Mixture (Beijing CoWin Biotech) according to the manufacturer's protocol. All real-time qPCR reactions were performed in the ABI PRISM 7700 sequence detection system (Applied Biosystems, Grand Island, NY, USA). In each reaction, 1 μl of cDNA, 10 μl of 2×RealSYBR Mixture, and 0.25 μM forward and reverse primers in a total volume of 20 μl were used. The reaction conditions were as follows: 1 cycle at 95°C for 5 min followed by 40 cycles at 95°C for 15 sec, annealing temperature for 30 sec and extension at 72°C for 30 sec. Real-time qPCR for each sample was run in triplicate. β-Actin was used as the internal control, and all results were analysed using the standard 2 -ΔΔCT method.
Western blot analysis
At the end of treatment, cell culture medium was discarded and cells were detached in PBS by scrapping. Detached cells were centrifuged at 15000 g at 4°C for 10 min. Cell pellets were then lysed in 300 μl of lysis buffers (Cytobuster protein extraction reagent, Novagen, Darmstadt, Germany) with 25 mM NaF, 1 mM Na 3 VO 4 , and 1×protease inhibitor cocktail. Protein concentrations were quantified by spectrophotometry. For Western blot, an equal amount of protein from each sample was loaded onto SDS-PAGE gels and electrotransferred onto PVDF membranes (Millipore, Bedford, MA, USA). These membranes were then blocked with 5% (w/v) bovine serum albumin in TBST [10 mM Tris, 150 mM NaCl, and 0.1% (v/v) Tween 20, pH = 7.5] for 1 h at room temperature, and incubated with primary antibodies overnight at 4°C. Secondary antibody incubation was at room temperature for 2 h (Santa Cruz Biotechnology). The secondary antibodies used for detection were horseradish peroxidase (HRP)-conjugated goat anti-rabbit immunoglobulin G (IgG) or HRP-conjugated goat anti-mouse IgG (both from Beyotime, Shanghai, China). Enhanced chemiluminescence (ECL; Beijing CoWin Biotech Co., Ltd.) was performed in order to detect immunoreactive protein signals. Protein signals were visualized and images were captured with a chemiluminescence detection system (MiniChemi™ III; Beijing Sage Creation Science Co., Ltd., Beijing, China) and quantified using ImageJ software (National Institutes of Health, Bethesda, MD, USA). For re-probing, the PVDF membranes were stripped 
Statistical analysis
The data were expressed as the means ± standard deviation (s.d.) for three or more independent experiments. Significant differences were determined using a factorial analysis of variance (ANOVA). Statistical analysis was performed using SPSS 13.0 software. A P-value <0.05 was considered to indicate a statistically significant difference and shown with an asterisk in the bar diagrams.
Results
Effect of quercetin on cell viability in MC3T3-E1 cells
MC3T3-E1 cells were treated with 10, 25 or 50 μM quercetin or without quercetin for 1, 3, 5, or 7 days. Cell viability was only inhibited by quercetin at day 5 and 7 ( Fig.  1 A) . Quercetin above 60 μM significantly inhibited cell viability in MC3T3-E1 cells stimulated with LPS at day 1 and 3 ( Fig. 1 B) .
Effect of pretreatment with quercetin on LPS-induced MC3T3-E1 cell apoptosis
MC3T3-E1 cells were pretreated with 5, 10, 15, 25 or 50 μM quercetin or without quercetin for 2 h, and then the cells were treated with 100 ng/ml LPS or without LPS in the presence of quercetin for 1 d. The number of fluorescence-positive osteoblasts was decreased with pretreatment of quercetin compared to the non-quercetintreated group or the LPS-treated groups in MC3T3-E1 cells after 24 h (Fig. 2) .
Effect of pretreatment with quercetin on the mineralized matrix in LPS-induced MC3T3-E1 cells
The effect of pretreatment with quercetin on the calcified nodules was visualized by alizarin red staining. After pretreatment with quercetin at 10, 25, or 50 μM or without quercetin for 2 h, MC3T3-E1 cells were incubated with LPS (100 ng/ml) for 3 d in the presence of quercetin. Then, cells were cultured only in osteogenic differentiation medium. At day 21 post-induction, the calcified nodules were visualized by alizarin red staining. The number of calcified nodules was increased with pretreatment of quercetin compared to the LPS-treated osteoblasts (Fig. 3) .
Effect of pretreatment with quercetin on the mRNA and protein expression of osteoblastspecific genes of LPS-induced MC3T3-E1 cells
MC3T3-E1 cells were pretreated with 5, 10, 15, 25 or 50 μM quercetin or without quercetin for 2 h, and then the cells were treated with 100 ng/ml LPS or without LPS in the presence of quercetin for 1 d. The results showed that pretreatment with quercetin significantly upregulated the mRNA and protein expression of osteoblast-specific genes such as ALP, Runx2, OSX and OCN in a dose-dependent manner after 1 d compared to the non-quercetin-treated group or the LPS-treated groups of MC3T3-E1 cells (Fig. 4 A, B and C). Following pretreatment with 50 μM quercetin or without quercetin for 2 h, MC3T3-E1 cells were treated with 100 ng/ml LPS or without LPS in the presence of quercetin for 0, 4, 8, 12, 24, or 48 h. The results also showed that pretreatment with quercetin significantly upregulated the protein expression levels of osteoblast-specific genes (Fig. 4 D) .
Effect of pretreatment with quercetin on the mRNA and protein expression of caspase-3, Bax, cytochrome c, Bcl-2 and Bcl-XL of LPS-induced MC3T3-E1 cells
MC3T3-E1 cells were pretreated with 5, 10, 15, 25 or 50 μM quercetin or without quercetin for 2 h, and then the cells were treated with 100 ng/ml LPS or without LPS in the presence of quercetin for 1 d. Pretreatment with quercetin significantly restored the downregulated expression of Bcl-2 and Bcl-XL while it decreased the upregulated expression of caspase-3, Bax, and cytochrome c compared to the non-quercetin-treated group or the LPStreated groups of MC3T3-E1 cells (Fig. 5) . 
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Effect of pretreatment with quercetin on protein expression of MAPK and Wnt/β-catenin in LPS-induced MC3T3-E1 cells
MC3T3-E1 cells were pretreated with 5, 10, 15, 25 and 50 μM quercetin or without quercetin for 2 h, and then the cells were treated with 100 ng/ml LPS or without LPS in the presence of quercetin for 30 min. Quercetin significantly enhanced the protein levels of p-ERK1/2, Wnt3 and β-catenin but decreased the protein levels of p-p38 and GSK-3β ( Fig. 6  and 7) .
Effect of MAPK and Wnt/β-catenin inhibitors on the protein expression of MAPK, Wnt/β-catenin, osteoblast-specific genes, caspase-3, Bax, cytochrome c, Bcl-2 and Bcl-XL of LPSinduced MC3T3-E1 cells with quercetin pretreatment
After treatment with dexamethasone (Dex) for 2 h, the MAPK inhibitors SP600125, PD98059, and SB203580 and the Wnt/β-catenin inhibitor XAV939 were applied for 2 h prior to pretreatment with 50 μM quercetin or without quercetin for 2 h; then cells were incubated with 100 ng/ml LPS or without LPS in the presence of quercetin for 30 min or 1 d. MAPK inhibitors significantly attenuated the quercetin-enhanced protein level of phosphorylated-ERK1/2 (by PD98059) and JNK (by SP600125) and restored the quercetininduced down-regulation in the protein expression of phosphorylated-p38 (by SB203580) (Fig. 8) . Moreover, MAPK inhibitors markedly attenuated the quercetin-enhanced protein expression of osteoblast-specific genes, Bcl-2 and Bcl-XL and restored the quercetin-induced down-regulation in the protein expression of caspase-3, Bax, and cytochrome c ( Fig. 9 and  10) . The Wnt/β-catenin inhibitor XAV939 also markedly attenuated the quercetin-enhanced protein expression of osteoblast-specific genes (Fig. 11) . Administration of dexamethasone 
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Cellular Physiology and Biochemistry also markedly attenuated the LPS-enhanced protein expression of MAPKs and the LPSinduced down-regulation of osteoblast-specific genes but reversed the quercetin-induced regulation of the phosphorylation of MAPKs and the protein expression of osteoblast-specific genes in MC3T3-E1 cells stimulated by LPS (Fig. 8-9 ).
Discussion
Excessive bone resorption in chronic inflammatory diseases such as septic arthritis, osteomyelitis, and infected orthopedic implant failure is at least partially caused by bacteriainduced activation of inflammatory responses [1] . LPS, a pro-inflammatory glycolipid component of the gram-negative bacterial cell wall, is a well-documented mediator of gram-negative bacterial bone destruction [2] [3] [4] [5] . Quercetin, a dietary flavonoid, has been reported anti-inflammatory properties [15, [25] [26] [27] ; however, whether the effect of quercetin on osteoblastogenesis is suppressive [16] [17] [18] or stimulatory [19] [20] [21] remains a matter of controversy. In this study, we found that cell viability was only inhibited by quercetin at high dosages after 5 and 7 d. In our previous study, we found quercetin treatment reversed LPSinduced inhibition of osteoblast differentiation through the MAPK pathway in MC3T3-E1 cells [22] . In this study, we found that pretreatment with quercetin could have protective effects against LPS-induced apoptosis and the inhibition of osteoblast differentiation.
The protective effect of pretreatment with quercetin on the LPS-induced inhibition of osteoblast differentiation is confirmed by evaluating quercetin's effect on the expression of osteoblast-specific genes. Runx2 (Cbfa1) and ALP have been suggested to be involved in the early-stage molecular events of osteoblast differentiation [31, 32] , whereas OSX and OCN are involved in the late-stage molecular events [23, 33, 34] . In this study, pretreatment with quercetin significantly restored the LPS-suppressed mRNA and protein expression of ALP, Runx2, OSX and OCN in MC3T3-E1 cells in a dose-dependent manner. Administration of dexamethasone also significantly attenuated the LPS-induced down-regulation of the protein expression of osteoblast-specific genes and reversed the quercetin-induced upregulation in protein expression of osteoblastspecific genes stimulated by LPS. Our data indicated that the protective effect of pretreatment with quercetin against LPS-induced inhibition of osteoblast differentiation could be due to 
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Cellular Physiology and Biochemistry the restoration of osteoblast-specific genes. The induction of osteoblast apoptosis results in further bacteria-induced bone destruction [1] . In one of our previous studies, we found that LPS had been shown to induce the apoptosis and inhibit osteoblast differentiation through the JNK pathway [9] . We evaluated the effect of pretreatment with quercetin on LPS-induced apoptosis in MC3T3-E1 cells. Our data showed that pretreatment with quercetin inhibited LPS-induced osteoblast apoptosis, using Hoechst 33258 staining, and significantly restored the downregulated expression of Bcl-2 and Bcl-XL while decreasing the upregulated expression of caspase-3, Bax, and cytochrome c compared to non-quercetin-treated cultures of MC3T3-E1 cells induced by LPS. These results indicated that pretreatment with quercetin could have a protective effect against LPS-induced osteoblast apoptosis. Moreover, pretreatment with quercetin enhanced the protein expression of p-ERK while down-regulating p-p38 MAPK expression in the MC3T3-E1 cells. Based on our results, we suggested that the protective effect of pretreatment with quercetin against LPS-induced osteoblast apoptosis is through the inhibition of the mitochondrial apoptosis pathway.
MAP kinases are activated by various stresses, including LPS, and influence apoptosis either positively or negatively [35] . In many cell types, JNK and p38 MAPK contribute to the induction of apoptosis, whereas ERK inhibits apoptotic processes [36] [37] [38] . In this study, pretreatment with quercetin enhanced the protein levels of phosphorylated ERK1/2, but Fig. 11 . Effect of the Wnt/β-catenin inhibitor on the protein expression of osteoblast-specific genes at 24 h with quercetin pretreatment in LPS-induced MC3T3-E1 cells. The Wnt/β-catenin inhibitor XV-939 were applied for 2 h prior to pretreatment with 50 μM quercetin or without quercetin for 2 h, and then cells were incubated with 100 ng/ml LPS or without LPS in the presence of quercetin for 24 h. The Wnt/β-catenin inhibitor markedly attenuated the quercetin-enhanced protein expression of osteoblastspecific genes.
reduced the protein levels of phosphorylated p38. Furthermore, after pretreatment with MAPK inhibitors for 2 h, the quercetin-enhanced p-MAPKs were attenuated; then, after pretreatment with MAPK inhibitors for 1 d, the quercetin-enhanced expression of osteoblastspecific genes was attenuated by p38-MAPK and ERK inhibitor respectively. MAPK inhibitors also attenuated the quercetin-enhanced expression of Bcl-2 and Bcl-XL, while enhancing the quercetin-down-regulated expression of caspase-3, Bax, and cytochrome c. Administration of dexamethasone also significantly attenuated the LPS-enhanced protein expression of MAPKs, while reversing the quercetin-induced regulation of the phosphorylation of MAPKs in LPS-induced MC3T3-E1 cells. Our study indicated that pretreatment with quercetin could reduce LPS-induced osteoblast apoptosis and restore inhibited osteoblast differentiation through MAPK signalling.
The Wnt/β-catenin signalling pathway also plays a vital role in regulating osteoblast differentiation and bone formation [28] [29] [30] . Wnts are categorized as canonical Wnt signalling, which requires signalling through β-catenin, or non-canonical Wnt signalling, which does not require β-catenin [39, 40] . Evidence suggests that the regulation of Wnt activation of β-catenin in osteoblasts is important for bone formation [41] . In the absence of Wnt ligands, β-catenin forms a multiprotein complex with casein kinase 1 (CK1), glycogen synthase kinase 3β (GSK3β), adenomatous polyposis coli (APC), and Axin, which drive β-catenin ubiquitination and degradation [42, 43] . In the presence of Wnt ligands, Wnt binds to the transmembrane receptor frizzled (Fzd) and co-receptor LRP5/6; GSK3-dependent phosphorylation of β-catenin will be prevented thus leading to the intracellular accumulation of β-catenin, which can then enter the nucleus and interact with the transcription factor T-cell factor/lymphoid enhancer factor (TCF/LEF) to activate the transcription of target genes [44, 45] . In this study, pretreatment with quercetin enhanced the protein levels of Wnt3 and β-catenin but reduced the protein levels of GSK3β. Furthermore, after pretreatment with a Wnt/β-catenin inhibitor (XAV939) for 1 d, the quercetin-enhanced expression of osteoblast-specific genes was attenuated. Our study also indicated that pretreatment with quercetin could restore the inhibition of osteoblast differentiation through the Wnt/β-catenin signalling pathway.
Conclusion
Our data suggests that pretreatment with quercetin could have protective effects against LPS-induced osteoblast apoptosis and against the inhibition of osteoblast differentiation via MAPK and Wnt/β-catenin signalling pathway. These results indicate that pretreatment with quercetin may be a potential drug for the prevention of human abnormal bone loss induced by LPS in chronic inflammatory diseases.
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